Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open‐label, multicenter study

Publisher： John Wiley & Sons Inc

E-ISSN： 2040-1124|9|1|127-136

ISSN： 2040-1116

Source： Journal Of Diabetes Investigation, Vol.9, Iss.1, 2018-01, pp. : 127-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open‐label, multicenter study

By  

Journal Of Diabetes Investigation, Vol. 9, Iss. 1, 2018-01 ,pp. : 108-118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus

By  

Journal Of Diabetes Investigation, Vol. 6, Iss. 4, 2015-07 ,pp. : 443-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Open‐label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin‐naïve Asian patients with type 2 diabetes

By  

Journal Of Diabetes Investigation, Vol. 9, Iss. 1, 2018-01 ,pp. : 100-107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

By  

Journal Of Diabetes Investigation, Vol. 9, Iss. 1, 2018-01 ,pp. : 119-126

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin–sulfonylurea combination: Results of a multicenter, cross‐sectional, observational study in Korea

By  

Journal Of Diabetes Investigation, Vol. 6, Iss. 3, 2015-05 ,pp. : 317-324

John Wiley & Sons Inc

Access to resources Recommend Favorite